To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in actual practice for treating patients with retinal diseases in Thailand.
Authors:
Suthasinee Kumluang, Lily Ingsrisawang, Sermsiri Sangroongruangsri, Usa Chaikledkaew, Tanapat Ratanapakorn, Paisan Ruamviboonsuk, Wongsiri Taweebanjongsin, Janejit Choovuthayakorn, Somanus Thoongsuwan, Prut Hanutsaha, Kittisak Kulvichit, Thitiporn Ratanapojnard, Warapat Wongsawad, Pattara Leelahavarong and Yot Teerawattananon
Citation:
BMC Ophthalmology
2019
19:82
Content type: Research article
Published on: 29 March 2019